REMUS — Remus Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹9.44bn
- IN₹9.66bn
- IN₹6.20bn
- 57
- 18
- 19
- 18
Annual cashflow statement for Remus Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 13.6 | 45.5 | 114 | 318 | 473 |
| Depreciation | |||||
| Non-Cash Items | -0.335 | -1.57 | -3.07 | -16.7 | -16.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13.4 | 4.91 | -62.7 | -274 | -406 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 28.4 | 50.4 | 53.1 | 36 | 69.9 |
| Capital Expenditures | -0.664 | -0.71 | -27.3 | -6.36 | -39.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30.2 | -44.7 | -125 | -83.1 | -65.7 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -30.9 | -45.5 | -152 | -89.4 | -106 |
| Financing Cash Flow Items | -0.35 | -0.872 | -2.33 | -162 | -15 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.15 | -1.74 | 118 | 244 | 60.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.68 | 3.18 | 18.9 | 190 | 25.1 |